Mission

There is an immense desire to better understand and monitor brain health. The mission of Encephalogix is to develop electroencephalogram (EEG) software that enables better diagnosis, treatment, and drug discovery for brain diseases.

Overview

Encephalogix has made a giant leap in the way we can detect, diagnose, and treat diseases of the human brain. Our innovation lies at the intersection of big data and physiology, enabling a non-invasive approach to accurately assess the presence of brain diseases and help identify the most appropriate drug treatment for patients.

Our product is a machine learning platform that makes sense of EEG data and serves up actionable, easily understandable pathology scores. Importantly, we can tie the pathology scores back to actual changes in neuronal signaling.

We have successfully applied our technology to epilepsy but have strong scientific rationale for its applicability to other CNS diseases, including Alzheimer’s, Parkinson’s, TBI, concussion, autism and depression.

Encephalogix serves many stakeholders in the brain health ecosystem, including doctors, EEG technicians, pre-clinical and clinical drug developers, insurance payors, government overseers. Most importantly, we serve the patients themselves: positively impacting patient care is our primary goal.

Technology

Our method of EEG analysis is unique and involves the conversion of the raw EEG data into multi-dimensional shapes. Using sophisticated machine learning algorithms, these shapes are then analyzed in a variety of methods, both as probability distributions among classes as well as sequences of shapes that can be evaluated similar to DNA or protein sequences. The output of this analysis is a probabilistic pathology score that can be used to classify the patient as well as follow the patient through time. Importantly, we can tie the score back to actual pathologies in neuronal signaling, with pinpoint precision.